重复体外生命支持对先天性膈疝新生儿死亡率及短期院内并发症的影响
该回顾性队列研究纳入1995至2019年先天性膈疝研究组登记中符合ECLS条件的CDH新生儿,排除胎龄<32周、出生体重<1.8 kg及重大心脏或染色体异常者。结果显示接受1个疗程ECLS者占30%,接受多疗程者占1.6%;未接受ECLS、1个疗程和多疗程患者的总体生存率分别为86.9±0.8%、53.8±1.8%和43.1±7.7%。在开展重复ECLS的中心治疗,总体ECLS生存率提高5.1±4.6%(P=0.03),但多疗程存活者院内并发症发生率最高。
要点
- CDH新生儿接受多疗程ECLS者生存率低于单疗程,但开展重复ECLS的中心总体生存率更高。
- 重复ECLS可能提高CDH新生儿总体生存,但需权衡院内并发症风险增加。
- 未接受ECLS的患儿并发症风险最低,多疗程ECLS存活者并发症发生率最高。
核心结论
- 尽管重复ECLS的生存率较低,但多疗程ECLS有可能提高CDH新生儿的总体生存率。
- 增加重复ECLS的使用可能与生存改善相关,但需权衡index住院期间并发症风险增加。
研究设计与样本
- 回顾性队列研究,纳入1995至2019年先天性膈疝研究组登记中所有符合ECLS条件的CDH新生儿。
- 排除胎龄<32周、出生体重<1.8 kg和/或重大心脏或染色体异常的CDH婴儿。
- 共10,089例符合ECLS条件的CDH婴儿,其中3,025例(30%)接受1个ECLS疗程,160例(1.6%)接受多个疗程。
主要发现
- 未接受ECLS、1个ECLS疗程和多疗程ECLS患者的总体生存率分别为86.9±0.8%、53.8±1.8%和43.1±7.7%。
- 在开展重复ECLS的中心治疗,CDH新生儿总体ECLS生存率提高5.1±4.6%(P=0.03)。
- 未接受ECLS支持的婴儿并发症风险最低,多疗程ECLS存活者index住院期间并发症发生率最高。
临床怎么用
- 对CDH新生儿考虑重复ECLS时,应权衡潜在总体生存获益与index住院期间并发症风险增加。
- 开展重复ECLS的中心可能获得更高的总体ECLS生存率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of repeat extracorporeal life support (ECLS) on survival and in-hospital outcomes in the congenital diaphragmatic hernia (CDH) neonates. BACKGROUND: Despite the widespread use of ECLS, investigations on multiple ECLS courses for CDH neonates are limited. METHODS: This is a retrospective cohort study of all ECLS-eligible CDH neonates enrolled in the Congenital Diaphragmatic Hernia Study Group registry between 1995 and 2019. CDH infants with estimated gestational age at birth <32 weeks and a birth weight <1.8 kg and/or with major cardiac or chromosomal anomalies were excluded. The primary outcomes were survival and morbidities during the index hospitalization. RESULTS: Of 10,089 ECLS-eligible CDH infants, 3025 (30%) received 1 ECLS course, and 160 (1.6%) received multiple courses. The overall survival rate for patients who underwent no ECLS, 1 ECLS course, and multicourse ECLS were 86.9±0.8%, 53.8±1.8%, and 43.1±7.7%, respectively. Overall ECLS survival rate is increased by 5.1±4.6% ( P =0.03) for CDH neonates treated at centers that conduct repeat ECLS compared with those that do not offer repeat ECLS. This suggests that there would be an overall survival benefit from increased use of multiple ECLS courses. Infants who did not receive ECLS support had the lowest morbidity risk, while survivors of multicourse ECLS had the highest rates of morbidities during the index hospitalization. CONCLUSIONS: Although survival is lower for repeat ECLS, the use of multiple ECLS courses has the potential to increase overall survival for CDH neonates. Increased use of repeat ECLS might be associated with improved survival. The potential survival advantage of repeat ECLS must be balanced against the increased risk of morbidities during the index hospitalization.
引用
- Danzer E, Harting MT, Dahlen A, et al. Impact of Repeat Extracorporeal Life Support on Mortality and Short-term In-hospital Morbidities in Neonates With Congenital Diaphragmatic Hernia. Ann Surg. 2022. PMID: 36102187. doi:10.1097/SLA.0000000000005706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。